W. Wysokinski

D. Hodge, R. McBane, W. Wysokinski, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis

R. McBane, W. Wysokinski, S. Baxi, 2008, Thrombosis and Haemostasis.

Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis

D. Hodge, G. Hesley, R. McBane, 2020, Thrombosis and Haemostasis.

Spontaneous Visceral Artery Dissections in Otherwise Normal Arteries: Clinical Features, Management, Outcomes Compared to Fibromuscular Dysplasia.

R. McBane, F. Shamoun, S. Naidu, 2020, Journal of vascular surgery.

Gating of thrombin in platelet aggregates by pO2-linked lowering of extracellular Ca2+ concentration.

J. Bichler, W. Wysokinski, W. Owen, 1995, Biochemistry.

Cerebral venous sinus thrombosis

H. Wiste, D. Grill, R. McBane, 2006, Neurology.

Clinical characteristics and long-term follow-up of patients with renal vein thrombosis.

H. Wiste, D. Grill, R. McBane, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban

David A. Froehling, D. Hodge, R. McBane, 2019, American journal of hematology.

Ovarian vein thrombosis: Incidence of recurrent venous thromboembolism and survival

K. Cohoon, P. Daniels, R. McBane, 2006, Thrombosis and Haemostasis.

Predicting superficial venous incompetence with strain gauge plethysmography

W. Wysokinski, N. Skeik, P. Wennberg, 2012, Phlebology.

Quadrilateral space syndrome: the Mayo Clinic experience with a new classification system and case series.

Sherry‐Ann Brown, P. Gloviczki, S. Naidu, 2015, Mayo Clinic proceedings.

Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes

D. Hodge, W. Wysokinski, A. Casanegra, 2021, Research and practice in thrombosis and haemostasis.

Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism.

David A. Froehling, D. Hodge, A. Ashrani, 2019, Mayo Clinic proceedings.

Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival

K. Cohoon, P. Daniels, R. McBane, 2018, European journal of haematology.

Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis

David A. Froehling, D. Hodge, P. Daniels, 2021, Journal of thrombosis and haemostasis : JTH.

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

C. Loprinzi, A. Ashrani, J. Le-Rademacher, 2018, Blood.

Iliac Venous Stenting: Antithrombotic Efficacy of PD0348292, an Oral Direct Factor Xa Inhibitor, Compared With Antiplatelet Agents in Pigs

R. McBane, W. Wysokinski, S. Baxi, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Apixaban and dalteparin in active malignancy associated venous thromboembolism.

C. Loprinzi, A. Ashrani, J. Le-Rademacher, 2017, Thrombosis and haemostasis.

Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation

R. McBane, R. Pruthi, W. Wysokinski, 2014, Journal of Thrombosis and Thrombolysis.

Platelet recruitment to venous stent thrombi

R. McBane, W. Wysokinski, K. Karnicki, 2013, Journal of Thrombosis and Thrombolysis.

Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.

N. Shah, J. Heit, R. McBane, 2013, International journal of cardiology.

Periprocedural bridging management of anticoagulation.

R. McBane, W. Wysokinski, 2012, Circulation.

Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome

David A. Froehling, D. Hodge, Ryan A. Meverden, 2022, Journal of Thrombosis and Thrombolysis.

Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism.

David A. Froehling, D. Hodge, Ryan A. Meverden, 2021, Mayo Clinic proceedings.

Calf Vein Thrombosis Outcomes Comparing Anticoagulation and Serial Ultrasound Imaging Management Strategies.

David A. Froehling, Ryan A. Meverden, P. Daniels, 2021, Mayo Clinic proceedings.

Calf vein thrombosis outcomes comparing patients with and without cancer

D. Hodge, W. Wysokinski, A. Casanegra, 2021, Journal of Thrombosis and Thrombolysis.

Submassive Pulmonary Embolism and Left Atrial Thrombus

K. Chandrasekaran, W. Wysokinski, N. Anavekar, 2018, CASE.

Iliac vein thrombosis: feasibility assessment of randomized controlled trials of endovascular pharmacomechanical thrombolysis

W. Wysokinski, H. Bjarnason, E. Wysokinska, 2010, Journal of thrombosis and haemostasis : JTH.

Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America

D. Grill, E. Sutkowska, K. Sutkowski, 2013, Journal of Gastroenterology.

Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis

D. Grill, R. McBane, R. Brown, 2008, Neurology.

Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients

R. McBane, S. Misra, R. Pruthi, 2021, Mayo Clinic Proceedings.

Treatment of venous thrombosis at unusual sites

R. McBane, W. Wysokinski, 2008, Current treatment options in cardiovascular medicine.

Acquired and congenital risk factors associated with cerebral venous sinus thrombosis.

R. McBane, W. Wysokinski, A. Tafur, 2010, Thrombosis research.

Role of Platelets in Thromboembolism in Patients with Atrial Fibrillation.

M. Wasilewska, W. Wysokinski, I. Gosk-Bierska, 2016, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Pulmonary artery capacitance and pulmonary vascular resistance as prognostic indicators in acute pulmonary embolism

H. Villarraga, W. Wysokinski, A. Casanegra, 2022, European heart journal open.

Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience.

R. McBane, P. Gloviczki, A. Kurklinsky, 2012, Journal of vascular and interventional radiology : JVIR.

Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis.

M. Murad, C. Loprinzi, I. Riaz, 2019, Mayo Clinic proceedings.

Iatrogenic Bleeding Disorders: AFIRE That Requires Your Attention

W. Wysokinski, D. Houghton, 2022, The Hematologist.

Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial index

Adelaide M. Arruda-Olson, Dennis H. Murphree, Itzhak Z. Attia, 2022, Vascular medicine.

Lipoma causing upper extremity deep vein thrombosis: A case report

J. Breen, W. Wysokinski, B. Palamari, 2010, Journal of Thrombosis and Thrombolysis.

Immunohistochemistry of thrombi following iliac venous stenting: A novel model of venous thrombosis

R. McBane, W. Wysokinski, K. Karnicki, 2006, Thrombosis and Haemostasis.

Adrenal haemorrhage due to heparin-induced thrombocytopenia

A. Vella, R. McBane, R. Pruthi, 2013, Thrombosis and Haemostasis.

Use of nontraditional anticoagulants in portal vein thrombosis: A note of caution

P. Kamath, D. Simonetto, W. Wysokinski, 2015, Hepatology.

Coagulation in diabetic and non-diabetic claudicants.

W. Wysokinski, R. Adamiec, I. Gosk-Bierska, 2002, International angiology : a journal of the International Union of Angiology.

PERI-PROCEDURAL ANTICOAGULATION MANAGEMENT OF MECHANICAL PROSTHETIC HEART VALVE PATIENTS

N. Shah, J. Heit, R. McBane, 2011 .

Weighing the Risk and Benefits of Direct Oral Anticoagulants in Morbidly Obese Patients: New Data and Guidance

W. Wysokinski, D. Houghton, 2021, The Hematologist.

Antiphospholipid antibodies in thromboangiitis obliterans

R. McBane, W. Wysokinski, L. Masłowski, 2002, Vascular medicine.

Propensity for young reticulated platelet recruitment into arterial thrombi

D. Hodge, R. McBane, W. Wysokinski, 2013, Journal of Thrombosis and Thrombolysis.

Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study

David A. Froehling, D. Hodge, A. Ashrani, 2022, European journal of haematology.

Antithrombotic Action of Endogenous Porcine Protein C Activated with a Latent Porcine Thrombin Preparation

J. Chesebro, R. McBane, W. Wysokinski, 1995, Thrombosis and Haemostasis.

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients.

D. Hodge, S. Litin, J. Heit, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Renal vein thrombosis - Etiology, diagnosis, therapeutic options

R. McBane, W. Wysokinski, I. Gosk-Bierska, 2006 .

Risk of venous thromboembolism after COVID‐19 vaccination

A. Ashrani, R. McBane, R. Pruthi, 2022, Journal of Thrombosis and Haemostasis.

Septic venous thromboembolism

R. McBane, W. Wysokinski, D. Golovyan, 2012, Vascular medicine.

Popliteal cysts are not a risk factor for lower extremity deep vein thrombosis

Ryan A. Meverden, P. Daniels, G. Hesley, 2022, Journal of Thrombosis and Thrombolysis.

Buerger's Disease in Two Brothers: Iliac Artery Occlusion by Thromboangiitis Obliterans

W. Wysokinski, W. Witkiewicz, L. Masłowski, 1998, Angiology.

Protein C deficiency associated with venous thromboembolism.

J. Vermylen, J. Arnout, R. Verhaeghe, 1990, Acta clinica Belgica.

Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score–Matched Analysis of 10 633 Patients

J. Seward, K. Bailey, S. Cha, 2017, Circulation.

Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation.

B. Gersh, K. Chandrasekaran, D. Hodge, 2018, The American journal of cardiology.

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents

Salma I. Patel, J. Salciccioli, R. McBane, 2018, Journal of clinical medicine.

Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation

B. Gersh, J. Oh, V. Nkomo, 2021, Heart.

Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi

R. McBane, W. Wysokinski, D. Fass, 2004, Journal of thrombosis and haemostasis : JTH.

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation

R. McBane, W. Wysokinski, J. Schaefer, 2015, Annals of Hematology.

Relationship between body mass index and left atrial appendage thrombus in nonvalvular atrial fibrillation

D. Grill, K. Cohoon, N. Ammash, 2016, Journal of Thrombosis and Thrombolysis.

The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation.

K. Cohoon, N. Ammash, R. McBane, 2015, International journal of cardiology.

Effect of atrial fibrillation duration on plasma von Willebrand factor level

S. Asirvatham, K. Cohoon, N. Ammash, 2017, European journal of haematology.

Impact of atrial fibrillation on platelet gene expression

Yanhong Wu, D. Grill, S. Asirvatham, 2017, European journal of haematology.

Association of Soluble CD40 Ligand With Duration of Atrial Fibrillation and With Intensity of Spontaneous Echocardiographic Contrast.

S. Asirvatham, K. Cohoon, N. Ammash, 2016, JACC. Clinical electrophysiology.

Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation

R. McBane, W. Wysokinski, S. Ketha, 2014, Expert review of cardiovascular therapy.

Left Atrial Blood Stasis and Von Willebrand Factor–ADAMTS13 Homeostasis in Atrial Fibrillation

Dong Chen, D. Grill, P. Friedman, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation

D. Hodge, R. McBane, W. Wysokinski, 2008, Thrombosis and Haemostasis.

Periprocedural Anticoagulant Management

R. McBane, W. Wysokinski, A. Tafur, 2012, Hospital practice.

Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location

P. Kamath, D. Hodge, R. McBane, 2018, Mayo Clinic proceedings.

Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.

P. Pellikka, R. McBane, R. Herges, 2007, Journal of vascular surgery.

Platelet factor XIII gene expression and embolic propensity in atrial fibrillation

Thomas G. McLeod, Yanhong Wu, R. McBane, 2011, Thrombosis and Haemostasis.

Hypercoagulable Conditions Leading to Limb Ischemia

R. McBane, W. Wysokinski, A. Jayaraj, 2017 .

Inhibition of Platelet-Rich Arterial Thrombus In Vivo: Acute Antithrombotic Effect of Intravenous HMG-CoA Reductase Therapy

R. McBane, W. Wysokinski, W. Owen, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients

R. McBane, W. Wysokinski, J. Garg, 2021, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

Individual propensity for arterial thrombosis.

R. McBane, W. Wysokinski, W. Owen, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation.

Thomas G. McLeod, K. Cohoon, N. Ammash, 2018, Thrombosis research.

Periprocedural Anticoagulation Management of Patients with Thrombophilia.

D. Hodge, S. Litin, J. Heit, 2016, The American journal of medicine.

Impact of Atrial Fibrillation and Sinus Rhythm Restoration on Reticulated Platelets.

D. Grill, S. Asirvatham, N. Ammash, 2015, Mayo Clinic proceedings.

Predicting left atrial thrombi in atrial fibrillation.

N. Ammash, R. McBane, H. Kalsi, 2010, American heart journal.

Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis

Adnan Ahmed, I. Riaz, R. McBane, 2021, Journal of Thrombosis and Thrombolysis.

DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta‐Analysis

M. Murad, R. McBane, W. Wysokinski, 2020, Journal of the American Geriatrics Society.

Sustained Classic Clinical Spectrum of Thromboangiitis Obliterans (Buerger's Disease)

W. Wysokinski, W. Kwiatkowska, B. Sapian-Raczkowska, 2000, Angiology.

Clinical spectrum of Raynaud's phenomenon in patients referred to vascular clinic.

W. Wysokinski, M. Knapik-Kordecka, 2000, Cardiovascular surgery.

In Reply.

R. McBane, W. Wysokinski, C. Lenz, 2018, Obstetrics and gynecology.

Clinical Spectrum of Raynaud's Phenomenon in Patients Referred to Vascular Clinic

W. Wysokinski, M. Knapik-Kordecka, 2000 .

Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation.

P. Noseworthy, B. Gersh, D. Hodge, 2020, The American journal of cardiology.

Venous thromboembolism after COVID‐19 vaccination in patients with thrombophilia

A. Ashrani, R. McBane, R. Pruthi, 2023, American journal of hematology/oncology.

Mesenteric vein thrombosis

R. McBane, W. Wysokinski, 2008 .

Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.

David A. Froehling, P. Kamath, A. Ashrani, 2022, Thrombosis research.

Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment

David A. Froehling, P. Daniels, I. Riaz, 2022, Thrombosis and Haemostasis.

Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.

W. Wysokinski, M. Davis, 2008, Journal of the American Academy of Dermatology.

Reduced calf muscle pump function is a risk factor for venous thromboembolism: A population-based cohort study.

D. Hodge, A. Ashrani, R. McBane, 2021, Blood.

Pneumatic Compression for Embolic Protection During Upper Extremity Endovascular Intervention

W. Edwards, G. Barsness, W. Wysokinski, 2014, Vascular and endovascular surgery.

Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?

J. Seward, P. Pellikka, W. Wysokinski, 1998, International angiology : a journal of the International Union of Angiology.

Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival.

K. Cohoon, P. Daniels, R. McBane, 2017, Obstetrics and gynecology.

Budd-Chiari syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio

T. Vrtiska, R. McBane, W. Wysokinski, 2010, Journal of Thrombosis and Thrombolysis.

Artificial intelligence of arterial Doppler waveforms to predict major adverse outcomes among patients evaluated for peripheral artery disease

Dennis H. Murphree, Itzhak Z. Attia, C. Scott, 2023, medRxiv.

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis

I. Riaz, F. Shamoun, W. Wysokinski, 2023, JAMA network open.

Calf muscle pump function as a predictor of all-cause mortality

Karen M. Fischer, G. Lin, R. McBane, 2020, Vascular medicine.

[Cardiovascular polypathy as a cause of death in elderly persons].

E. Poniewierka, A. Markowska, W. Wysokinski, 1987, Wiadomosci lekarskie.

Reversibility of Platelet Thrombosis In Vivo

J. Chesebro, R. McBane, W. Wysokinski, 1996, Thrombosis and Haemostasis.

Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.

J. Heit, M. Patnaik, A. Ashrani, 2016, European journal of internal medicine.

Do heterozygous and homozygous Factor V Leiden carriers differ regarding risk for incident and recurrent venous thromboembolism ? A retrospective cohort study

J. Heit, M. Patnaik, A. Ashrani, 2016 .

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation

B. Gersh, J. Oh, Zhenzhen Wang, 2020, Open Heart.

Images in Vascular Medicine Septic venous thromboembolism

R. McBane, W. Wysokinski, D. Golovyan, 2012 .

Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience.

R. McBane, P. Gloviczki, A. Kurklinsky, 2012, Journal of vascular and interventional radiology : JVIR.

Left Atrial Blood Stasis and Von Willebrand Factor–ADAMTS13 Homeostasis in Atrial Fibrillation

Thomas G. McLeod, Dong Chen, D. Grill, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Cerebral venous sinus thrombosis

H. Wiste, W. Wysokinski, E. Wysokinska, 2006, Neurology.

Inhibition of Platelet-Rich Arterial Thrombus In Vivo: Acute Antithrombotic Effect of Intravenous HMG-CoA Reductase Therapy

R. McBane, W. Wysokinski, W. Owen, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Cancer-associated non-bacterial thrombotic endocarditis-Clinical series from a single institution.

W. Wysokinski, E. Wysokinska, Wiktoria Kuczmik, 2024, American journal of hematology.

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

David A. Froehling, D. Hodge, A. Ashrani, 2019, Blood.

Abstract 5796: Unique Atrial Fibrillation Subpopulations: Thromboembolic Destination Predicts Recurrence Rates and Survival

Thomas G. McLeod, R. McBane, W. Wysokinski, 2009, Circulation.